Vitane Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Vitane Pharmaceuticals

Access the complete profile.

Vitane Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Address	125 Wells Avenue Congers, NY 10920

Note: Revenues for privately held companies are statistical evaluations.


Vitane Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Vitane Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Vitane Pharmaceuticals is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Vitane Pharmaceuticals Annual Revenue and Growth Rate

Vitane Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Vitane Pharmaceuticals's revenues are gauged from an analysis of company filings.

Vitane Pharmaceuticals's Income Statement (based on Industry Averages)

Vitane Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Vitane Pharmaceuticals is developing and marketing. Vitane Pharmaceuticals doesn't have any recent trademark applications, indicating Vitane Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
IROGLOBIN Multivitamin preparations; Vitamins and vitamin preparations	04/11/2023
DR WELLME NUTRITION Dietary and nutritional supplements	07/28/2020
CANNABI NATURALS Dietary and nutritional supplements; dietary supplement drinks and drink mixes; dietary food supplements; dietary and nutritional supplements for use as ingredients in foods and beverages	10/09/2019

See all trademarks and details in the Full Report.

Market Share of Vitane Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Vitane Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Vitane Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ADH HEALTH PRODUCTS	Congers, NY	100
VITANE PHARMACEUTICALS	Congers, NY	37
LIPTIS PHARMACEUTICALS USA	Spring Valley, NY	29
CEROVENE	Valley Cottage, NY	14
CHESS MEDICINE PLLC	Suffern, NY	5
MARIE ORIGINALS FORMULAS	Pearl River, NY	4

Future Competition: Vitane Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Vitane Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)